Pfizer Files Patent Suit In New Jersey Federal Court Over Proposed Generic

(November 18, 2020, 2:02 PM EST) -- TRENTON, N.J. — Efforts by Dr. Reddy’s Laboratories Inc. (DRL) to develop and market a generic form of the breast cancer treatment drug “Ibrance” represent patent infringement, Pfizer Inc. asserts in...
To view the full article, register now.